PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This is an open-label, parallel-group study to compare the pharmacokinetics and
pharmacodynamics of IDN-6556 following a single 50 mg oral dose of IDN-6556 in subjects with
severe renal impairment and matched healthy volunteers with normal renal function.